Waltz to Serve on NIH Study Section
Susan Waltz, PhD, professor of cancer biology and member of both the Cincinnati Cancer Center and the UC Cancer Institute, has been asked to serve on the Cancer Molecular Pathology Study Section for the National Institutes of Health, for the term beginning July 1, 2014 and ending June 30, 2020.
The Cancer Molecular Pathobiology [CAMP] Study Section reviews applications involving the pathology of the malignant cell with the emphasis on mechanisms controlling cell growth and death, and the molecular events in gene regulation.
Emphasis is on pathological approaches to oncogenesis and the basic cellular events involving growth of transformed cells in animal models, with more translational studies in human cells.
Tags
Related Stories
On-site training in Speech & Hearing Clinic sets UC’s programs apart
August 27, 2026
At the University of Cincinnati’s Speech & Hearing Clinic, Doctor of Audiology and Speech-Language Pathology graduate students gain real-world experience while providing free speech and hearing services to the community.
Funding expands UC research into weight gain side effects of bipolar medication
August 26, 2026
University of Cincinnati researchers have been approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) to expand the implementation of healthy lifestyle interventions and metformin prescription to help manage weight gain in overweight or obese youth taking second-generation antipsychotic medications.
One in four NFL players had CTE at death
August 25, 2026
Forbes cites research on concussions and football helmets by the University of Cincinnati in a report that found one in four NFL players had brain damage at death.